The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Regenass, U., & Lydon, N. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2558 · Cited by 270
RetractedMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Self-citationROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Self-citationClinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Self-citationDruker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Self-citationStructural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Self-citationSawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,621
Shah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J., & Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00096-x · Cited by 1,612
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
Prognostic discrimination in "good-risk" chronic granulocytic leukemia
Sokal, J., Cox, E., Baccarani, M., Tura, S., Gomez, G., Robertson, J., Tso, C., Braun, T., Clarkson, B., & Cervantes, F. (1984) · Blood · doi:10.1182/blood.v63.4.789.789 · Cited by 1,214
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Sawyers, C. L. (2002) · Blood · doi:10.1182/blood.v99.10.3530 · Cited by 1,146
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Self-citationTalpaz, M. (2002) · Blood · doi:10.1182/blood.v99.6.1928 · Cited by 1,019
Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Löffler, H., Sauerland, C. M., Serve, H., Büchner, T., et al. (2002) · Blood · doi:10.1182/blood.v100.1.59 · Cited by 973
Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T. H., Veach, D. R., Miller, W. T., Clarkson, B. D., & Kuriyan, J. (2002) · PubMed · Cited by 923
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Hochhaus, A., Kreil, S., Corbin, A., La Rosée, P., Müller, M., Lahaye, T., Hanfstein, B., Schoch, C., Cross, N., Berger, U., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402741 · Cited by 906
Self-citationStructural Basis for the Autoinhibition of c-Abl Tyrosine Kinase
Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G., & Kuriyan, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00194-6 · Cited by 879
Hasford, J., Pfirrmann, M., Hehlmann, R., Allan, N. C., Baccarani, M., Kluin-Nelemans, J. C., Alimena, G., Steegmann, J. L., & Ansari, H. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.850 · Cited by 819
Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755
Bartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 747
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 672
Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.
Marais, R., Light, Y., Paterson, H. F., & Marshall, C. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07316.x · Cited by 612
Mahon, F. X., Deininger, M. W. N., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.3.1070 · Cited by 584
Self-citation(1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301204 · Cited by 577
Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
Hansen, J. A., Gooley, T. A., Martin, P. J., Appelbaum, F., Chauncey, T. R., Clift, R. A., Petersdorf, E. W., Radich, J., Sanders, J. E., Storb, R. F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381405 · Cited by 570
Ottmann, O. G. (2002) · Blood · doi:10.1182/blood-2001-12-0181 · Cited by 555
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Self-citationInterferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia
Guilhot, F., Chastang, C., Michallet, M., Guerci, A., Harousseau, J.-L., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370402 · Cited by 543
Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 539
Roche-Lestienne, C., Soenen-Cornu, V., Grardel-Duflos, N., Laı̈, J.-L., Philippe, N., Facon, T., Fenaux, P., & Preudhomme, C. (2002) · Blood · doi:10.1182/blood.v100.3.1014 · Cited by 515
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J., Sharkis, S., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 508
le Coutre, P., Tassi, E., Varella-Garcia, M., Barni, R., Mologni, L., Cabrita, G., Marchesi, E., Supino, R., & Gambacorti-Passerini, C. (2000) · Blood · doi:10.1182/blood.v95.5.1758.005a41_1758_1766 · Cited by 484
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
Deininger, M. W. N., Goldman, J. M., Lydon, N., & Melo, J. V. (1997) · Blood · doi:10.1182/blood.v90.9.3691 · Cited by 482
Self-citationA Myristoyl/Phosphotyrosine Switch Regulates c-Abl
Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., & Superti-Furga, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00191-0 · Cited by 480
Interaction between ATM protein and c-Abl in response to DNA damage
Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., et al. (1997) · Nature · doi:10.1038/387520a0 · Cited by 478
Bcr encodes a GTPase-activating protein for p21rac
Diekmann, D., Brill, S., Garrett, M. D., Totty, N., Hsuan, J., Monfries, C., Hall, C., Lim, L., & Hall, A. (1991) · Nature · doi:10.1038/351400a0 · Cited by 477
von Bubnoff, N., Schneller, F., Peschel, C., & Duyster, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07679-1 · Cited by 464
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 464
Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M., & Melo, J. V. (1998) · Blood · doi:10.1182/blood.v92.9.3362 · Cited by 463
Self-citationCytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia
Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 454
Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H., Pralle, H., Hossfeld, D., Queisser, W., Loffler, H., Hochhaus, A., & Heinze, B. (1994) · Blood · doi:10.1182/blood.v84.12.4064.bloodjournal84124064 · Cited by 448
Gordon, M. Y., Dowding, C. R., Riley, G. P., Goldman, J. M., & Greaves, M. F. (1987) · Nature · doi:10.1038/328342a0 · Cited by 436
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 420
Lymphosarcoma: virus-induced thymic-independent disease in mice.
Abelson, H. T., & Rabstein, L. S. (1970) · PubMed · Cited by 409
Skorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M., Wen, S., Zon, G., Gewirtz, A., Perussia, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 404
Weisberg, E., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.11.3498 · Cited by 401
BONE MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Ansen, J. O. A. H., Ooley, A. G., Artin, P. A. J. M., et al. (1998) · Cited by 400
Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation
Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., & Baltimore, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80646-7 · Cited by 397
Dominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 397
Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G. N., Salvatore, F., & Rotoli, B. (1996) · Blood · doi:10.1182/blood.v88.7.2410.bloodjournal8872410 · Cited by 387
Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J. M., & Gutterman, J. U. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-532 · Cited by 382
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Cross, N. C. P., Feng, L., Chase, A., Bungey, J., Hughes, T., & Goldman, J. M. (1993) · Blood · doi:10.1182/blood.v82.6.1929.1929 · Cited by 365
Bedi, A., Barber, J., Bedi, G., el-Deiry, W., Sidransky, D., Vala, M., Akhtar, A., Hilton, J., & Jones, R. (1995) · Blood · doi:10.1182/blood.v86.3.1148.1148 · Cited by 349
Schwartzberg, P. L., Stall, A. M., Hardin, J. D., Bowdish, K. S., Humaran, T., Boast, S., Harbison, M. L., Robertson, E. J., & Goff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90012-n · Cited by 348
Canellos, G. P. (1976) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31845-4 · Cited by 343
Cycling, stressed-out and nervous: cellular functions of c-Abl
Van Etten, R. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01549-4 · Cited by 321
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Bonifazi, F., de Vivo, A., Rosti, G., Guilhot, F., Guilhot, J., Trabacchi, E., Hehlmann, R., Hochhaus, A., Shepherd, P. C. A., Steegmann, J. L., et al. (2001) · Blood · doi:10.1182/blood.v98.10.3074 · Cited by 321
McWhirter, J. R., & Wang, J. Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05797.x · Cited by 317
Gambacorti-Passerini, C., le Coutre, P., Mologni, L., Fanelli, M., Bertazzoli, C., Marchesi, E., Di Nicola, M., Biondi, A., Corneo, G. M., Belotti, D., et al. (1997) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.1997.0155 · Cited by 316
Thiesing, J. T., Ohno-Jones, S., Kolibaba, K. S., & Druker, B. J. (2000) · Blood · doi:10.1182/blood.v96.9.3195 · Cited by 309
Self-citationTreatment of hypereosinophilic syndrome with imatinib mesilate
Gleich, G. J., Leiferman, K. M., Pardanani, A., Tefferi, A., & Butterfield, J. H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08505-7 · Cited by 306
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Kelly, L. M., Yu, J.-C., Boulton, C. L., Apatira, M., Li, J., Sullivan, C. M., Williams, I., Amaral, S. M., Curley, D. P., Duclos, N., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00070-3 · Cited by 305
Chronic myelogenous leukemia in blast crisis
Kantarjian, H. M., Keating, M. J., Talpaz, M., Walters, R. S., Smith, T. L., Cork, A., McCredie, K. B., & Freireich, E. J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90754-6 · Cited by 277
The nuclear tyrosine kinase c-abl negatively regulates cell growth
Sawyers, C. L., McLaughlin, J., Goga, A., Havlik, M., & Witte, O. (1994) · Cell · doi:10.1016/0092-8674(94)90240-2 · Cited by 275
Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl
Chen, G., Yuan, S.-S. F., Liu, W., Xu, Y., Trujillo, K., Song, B., Cong, F., Goff, S. P., Wu, Y., Arlinghaus, R., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12748 · Cited by 274
Oda, T., Heaney, C., Hagopian, J. R., Okuda, K., Griffin, J. D., & Druker, B. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31596-x · Cited by 272
Self-citationDai, Z., & Pendergast, A. M. (1995) · Genes & Development · doi:10.1101/gad.9.21.2569 · Cited by 269
Molecular Cloning Of Human Paxillin, a Focal Adhesion Protein Phosphorylated by P210BCR/ABL
Salgia, R., Li, J.-L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5039 · Cited by 267
Wen, S.-T., & Van Etten, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 265
The BCR gene encodes a novel serine/threonine kinase activity within a single exon
Maru, Y., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90521-y · Cited by 264
Kano, Y., Akutsu, M., Tsunoda, S., Mano, H., Sato, Y., Honma, Y., & Furukawa, Y. (2001) · Blood · doi:10.1182/blood.v97.7.1999 · Cited by 262
Corbin, A. S., Rosée, P. L., Stoffregen, E. P., Druker, B. J., & Deininger, M. W. (2003) · Blood · doi:10.1182/blood-2002-12-3659 · Cited by 258
Self-citationThe novel activation of ABL by fusion to an ets-related gene, TEL.
Papadopoulos, P., Ridge, S. A., Boucher, C. A., Stocking, C., & Wiedemann, L. M. (1995) · PubMed · Cited by 256
Holtz, M. S., Slovak, M. L., Zhang, F., Sawyers, C. L., Forman, S. J., & Bhatia, R. (2002) · Blood · doi:10.1182/blood.v99.10.3792 · Cited by 253
Roumiantsev, S., Shah, N. P., Gorre, M. E., Nicoll, J., Brasher, B. B., Sawyers, C. L., & Van Etten, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162140299 · Cited by 253
Functional interaction between DNA-PK and c-Abl in response to DNA damage
Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yuan, Z.-M., Weichselbaum, R., Weaver, D., & Kufe, D. (1997) · Nature · doi:10.1038/386732a0 · Cited by 251
Shi, Y., Alin, K., & Goff, S. P. (1995) · Genes & Development · doi:10.1101/gad.9.21.2583 · Cited by 247
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336
Hoover, R. R., Mahon, F.-X., Melo, J. V., & Daley, G. Q. (2002) · Blood · doi:10.1182/blood.v100.3.1068 · Cited by 241
Perkins, C., Kim, C. N., Fang, G., & Bhalla, K. N. (2000) · Blood · doi:10.1182/blood.v95.3.1014.003k04_1014_1022 · Cited by 232
Gorre, M. E., Ellwood-Yen, K., Chiosis, G., Rosen, N., & Sawyers, C. L. (2002) · Blood · doi:10.1182/blood-2002-05-1361 · Cited by 227
Jiang, X., Lopez, A., Holyoake, T., Eaves, A., & Eaves, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12804 · Cited by 227
Shaughnessy, J., Gabrea, A., Qi, Y., Brents, L., Zhan, F., Tian, E., Sawyer, J., Barlogie, B., Bergsagel, P. L., & Kuehl, M. (2001) · Blood · doi:10.1182/blood.v98.1.217 · Cited by 223
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells
Klejman, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf562 · Cited by 222
Bumm, T., Müller, C., Al-Ali, H.-K., Krohn, K., Shepherd, P., Schmidt, E., Leiblein, S., Franke, C., Hennig, E., Friedrich, T., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2053 · Cited by 221
Self-citationp53 in chronic myelogenous leukemia in acute phase.
Feinstein, E., Cimino, G., Gale, R. P., Alimena, G., Berthier, R., Kishi, K., Goldman, J., Zaccaria, A., Berrebi, A., & Canaani, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6293 · Cited by 220
Regulation of Rad51 Function by c-Abl in Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Kharbanda, S., Wang, R., Sung, P., Shinohara, A., Weichselbaum, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3799 · Cited by 218
An intramolecular SH3-domain interaction regulates c-Abl activity
Barilá, D., & Superti-Furga, G. (1998) · Nature Genetics · doi:10.1038/ng0398-280 · Cited by 216
Current trends in hematopoietic stem cell transplantation in Europe
Gratwohl, A., Baldomero, H., Horisberger, B., Schmid, C., Passweg, J., & Urbano-Ispizua, A. (2002) · Blood · doi:10.1182/blood-2002-03-0675 · Cited by 214
Or, R., Shapira, M. Y., Resnick, I., Amar, A., Ackerstein, A., Samuel, S., Aker, M., Naparstek, E., Nagler, A., & Slavin, S. (2003) · Blood · doi:10.1182/blood-2002-02-0535 · Cited by 210
Rosée, P. G. L., Corbin, A. S., Stoffregen, E. P., Deininger, M. W., & Druker, B. J. (2002) · PubMed · Cited by 203
Self-citationSTAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells
Sillaber, C., Gesbert, F., Frank, D. A., Sattler, M., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.6.2118 · Cited by 198
Sexl, V., Piekorz, R., Moriggl, R., Rohrer, J., Brown, M. P., Bunting, K. D., Rothammer, K., Roussel, M. F., & Ihle, J. N. (2000) · Blood · doi:10.1182/blood.v96.6.2277 · Cited by 198
Sill, H., Goldman, J., & Cross, N. (1995) · Blood · doi:10.1182/blood.v85.8.2013.bloodjournal8582013 · Cited by 197
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia
Melo, J., Gordon, D., Cross, N., & Goldman, J. (1993) · Blood · doi:10.1182/blood.v81.1.158.158 · Cited by 197
Increased neutrophil respiratory burst in bcr-null mutants
Voncken, J. W., Schaick, H. V., Kaartinen, V., Deemer, K., Coates, T., Landing, B., Pattengale, P., Dorseuil, O., Bokoch, G. M., Groffen, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90350-x · Cited by 197
Yu, C., Krystal, G. W., Varticovksi, L., McKinstry, R. P., Rahmani, M., Dent, P., & Grant, S. (2002) · PubMed · Cited by 191
Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase
Yuan, Z.-M., Huang, Y., Ishiko, T., Kharbanda, S., Weichselbaum, R., & Kufe, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1437 · Cited by 191
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer, B. J., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2883 · Cited by 178
Beran, M., Cao, X., Estrov, Z., Jeha, S., Jin, G., O'Brien, S. M., Talpaz, M., Arlinghaus, R. B., Lydon, N., & Kantarjian, H. M. (1998) · PubMed · Cited by 176
Peters, D. G., Hoover, R. R., Gerlach, M. J., Koh, E. Y., Zhang, H., Choe, K., Kirschmeier, P., Bishop, W. R., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.5.1404 · Cited by 173
Topaly, J., Zeller, W., & Fruehauf, S. (2001) · Leukemia · doi:10.1038/sj.leu.2402041 · Cited by 170
Leukemia in Hiroshima Atomic Bomb Survivors
HEYSSEL, R., BRILL, A. B., WOODBURY, L. A., NISHIMURA, E. T., GHOSE, T., HOSHINO, T., & YAMASAKI, M. (1960) · Blood · doi:10.1182/blood.v15.3.313.313 · Cited by 168
Baccarani, M., Rosti, G., de Vivo, A., Bonifazi, F., Russo, D., Martinelli, G., Testoni, N., Amabile, M., Fiacchini, M., Montefusco, E., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1527 · Cited by 166
Analysis of the Structural Basis of Specificity of Inhibition of the Abl Kinase by STI571
Corbin, A. S., Buchdunger, E., Pascal, F., & Druker, B. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111525200 · Cited by 162
Self-citationInhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A
Uehara, Y., Murakami, Y., Mizuno, S., & Kawalt, S. (1988) · Virology · doi:10.1016/0042-6822(88)90649-6 · Cited by 162
Dorsey, J. F., Jove, R., Kraker, A. J., & Wu, J. (2000) · PubMed · Cited by 151
Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571
Klejman, A., Rushen, L., Morrione, A., Słupianek, A., & Skórski, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205724 · Cited by 149
P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo, J. V., Myint, H., Galton, D. A. G., & Goldman, J. M. (1994) · PubMed · Cited by 143
The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway.
Cortez, D., Stoica, G., Pierce, J. H., & Pendergast, A. M. (1996) · PubMed · Cited by 138
Deininger, M. W., Vieira, S., Mendiola, R., Schultheis, B. S., Goldman, J. M., & Melo, J. V. (2000) · PubMed · Cited by 137
Self-citationMillion, R. P., & Etten, R. A. V. (2000) · Blood · doi:10.1182/blood.v96.2.664 · Cited by 136
Warmuth, M., Simon, N., Mitina, O., Mathes, R., Fabbro, D., Manley, P. W., Buchdunger, E., Forster, K., Moarefi, I., & Hallek, M. J. (2002) · Blood · doi:10.1182/blood-2002-01-0288 · Cited by 134
Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate
Anafi, M., Gazit, A., Zehavi, A., Ben‐Neriah, Y., & Levitzki, A. (1993) · Blood · doi:10.1182/blood.v82.12.3524.3524 · Cited by 133
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
Kantarjian, H., O'Brien, S., Keating, M. J., Beran, M., Estey, E. H., Giralt, S. A., Kornblau, S. M., Rios, M., Vos, D. D., & Talpaz, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400796 · Cited by 130
Kovalenko, M. V., Rönnstrand, L., Heldin, C., Loubtchenkov, M., Gazit, A., Levitzki, A., & Böhmer, F. (1997) · Biochemistry · doi:10.1021/bi962553l · Cited by 129
Ron, D., Zannini, M., Lewis, M., Wickner, R. B., Hunt, L. T., Graziani, G., Tronick, S. R., Aaronson, S. A., & Eva, A. (1991) · PubMed · Cited by 128
Integrins Regulate the Association and Phosphorylation of Paxillin by c-Abl
Lewis, J. M., & Schwartz, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14225 · Cited by 127
Dan, S., Naito, M., & Tsuruo, T. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400400 · Cited by 126
Warmuth, M., Bergmann, M., Prieß, A., Häuslmann, K., Emmerich, B., & Hallek, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33260 · Cited by 120
Mow, B. M. F., Chandra, J., Svingen, P. A., Hallgren, C. G., Weisberg, E., Kottke, T. J., Narayanan, V. L., Litzow, M. R., Griffin, J. D., Sausville, E. A., et al. (2002) · Blood · doi:10.1182/blood.v99.2.664 · Cited by 115
O'Dwyer, M. E., Gatter, K. M., Loriaux, M., Druker, B. J., Olson, S. B., Magenis, R. E., Lawce, H. J., Mauro, M. J., Maziarz, R. T., & Braziel, R. M. (2003) · Leukemia · doi:10.1038/sj.leu.2402848 · Cited by 114
Self-citationKantarjian, H. M., Keating, M., Estey, E., O'Brien, S., Pierce, S. A., Beran, M., Koller, C. A., Feldman, E. J., & Talpaz, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.772 · Cited by 112
Petzer, A., Eaves, C. J., Lansdorp, P., Ponchio, L., Barnett, M. J., & Eaves, A. (1996) · Blood · doi:10.1182/blood.v88.6.2162.bloodjournal8862162 · Cited by 107
Stevens–Johnson syndrome after treatment with STI571: a case report
Hsiao, L., Chung, H.-J., Lin, J., Chiou, T.-J., Liu, H., Fan, F. S., Wang, W.-S., Yen, C., & Chen, P. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03499.x · Cited by 105
Shiotsu, Y., Neckers, L. Μ., Wortman, I. A., An, W. G., Schulte, T. W., Soga, S., Murakata, C., Tamaoki, T., & Akinaga, S. (2000) · Blood · doi:10.1182/blood.v96.6.2284 · Cited by 102
Wolff, N. C., & Ilaria, R. L. (2001) · Blood · doi:10.1182/blood.v98.9.2808 · Cited by 102
Canitrot, Y., Lautier, D., Laurent, G., Fréchet, M., Ahmed, A. A., Turhan, A. G., Salles, B., Cazaux, C., & Hoffmann, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202619 · Cited by 101
Rosée, P. G. L., O'Dwyer, M. E., & Druker, B. J. (2002) · Leukemia · doi:10.1038/sj.leu.2402555 · Cited by 100
Self-citationImatinib Mesylate and Gray Hair
Étienne, G., Cony‐Makhoul, P., & Mahon, F. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208083470614 · Cited by 95
Rosée, P. G. L., Johnson, K. J., O'Dwyer, M. E., & Druker, B. J. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00836-6 · Cited by 95
Self-citationTyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh, A., Miyazawa, K., Ohyashiki, K., et al. (1995) · PubMed · Cited by 83
Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation.
Deininger, M. W., Bose, S., Góra‐Tybor, J., Yan, X. H., Goldman, J. M., & Melo, J. V. (1998) · PubMed · Cited by 82
Self-citationBCR-ABL–induced adhesion defects are tyrosine kinase–independent
Wertheim, J. A., Forsythe, K., Druker, B. J., Hammer, D. A., Boettiger, D. C., & Pear, W. S. (2002) · Blood · doi:10.1182/blood.v99.11.4122 · Cited by 82
Self-citationKaur, G., Gazit, A., Levitzki, A., Stowe, E., Cooney, D. A., & Sausville, E. A. (1994) · PubMed · Cited by 80
Amos, T. A. S., Lewis, J. L., Grand, F. H., Gooding, R. P., Goldman, J. M., & Gordon, M. Y. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05308.x · Cited by 79
The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein
Takeda, N., Shibuya, M., & Maru, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.203 · Cited by 79
Marley, S. B., Deininger, M. W., Davidson, R. J., Goldman, J. M., & Gordon, M. Y. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00142-9 · Cited by 79
Self-citationSignaling by ABL oncogenes through cyclin D1.
Afar, D., McLaughlin, J., Sherr, C. J., Witte, O. N., & Roussel, M. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9540 · Cited by 78
Tyrphostin induced growth inhibition
Kaur, G., Gazit, A., Levitzki, A., Stowe, E., Cooney, D. A., & Sausville, E. A. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199404000-00013 · Cited by 78
Ricci, C., Scappini, B., Divoký, V., Gatto, S., Onida, F., Verstovšek, S., Kantarjian, H. M., & Beran, M. (2002) · PubMed · Cited by 75
Li, S., Gillessen, S., Tomasson, M. H., Dranoff, G., Gilliland, D. G., & Etten, R. A. V. (2001) · Blood · doi:10.1182/blood.v97.5.1442 · Cited by 74
Ilaria, R. J., & Etten, R. A. V. (1995) · Blood · doi:10.1182/blood.v86.10.3897.bloodjournal86103897 · Cited by 71
Okabe, M., Uehara, Y., Miyagishima, T., Itaya, T., Tanaka, M., Kunieda, Y., Kurosawa, M., & Miyazaki, T. (1992) · Blood · doi:10.1182/blood.v80.5.1330.1330 · Cited by 69
Gastrointestinal Stromal Tumors
Zalcberg, J. R., Yip, D., Hemmings, C. T., Mann, G. B., & Blanke, C. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-13306-0_6 · Cited by 68
Dazzi, F., & Goldman, J. M. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199911000-00007 · Cited by 47
Kasper, B., Fruehauf, S., Schiedlmeier, B., Buchdunger, E., Ho, A. D., & Zeller, W. J. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051001 · Cited by 42
Crystal Structure of the c-Abl Kinase domain in complex with PD173955
Nagar, B., Bornmann, W., Pellicena, P., Schindler, T., Veach, D. R., Miller, W. T., Clarkson, B., & Kuriyan, J. (2002) · Worldwide Protein Data Bank · doi:10.2210/pdb1m52/pdb · Cited by 30
Cited by
Clinical Pharmacokinetics of Imatinib
Peng, B., Lloyd, P., & Schran, H. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544090-00001 · Cited by 665
A historical overview of protein kinases and their targeted small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.010 · Cited by 526
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Ling, Y., Hao, Z.-Y., Liang, D., Zhang, C.-L., Liu, Y.-F., & Wang, Y. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s329547 · Cited by 414
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
Niazi, S. K., & Mariam, Z. (2023) · Pharmaceuticals · doi:10.3390/ph17010022 · Cited by 336
Metadata
- Authors
- Deininger, M. W. N., & Druker, B. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 55
- Issue
- 3
- Pages
- 401-423
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2102610315
- Cited by
- 365
- References
- 163
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.